⌘K

Home/Filings/4/0000950142-22-000997

4//SEC Filing

Besthof Robert 4

Accession 0000950142-22-000997

CIK 0001719406other

View on SEC.gov Company Profile

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 4:04 PM ET

Size

5.5 KB

Accession

0000950142-22-000997

Insider Transaction Report

Form 4

Period: 2022-03-08

NRX Pharmaceuticals, Inc.NRXP

Chief Comm. & Patient Officer

Transactions

Award
Employee Stock Option
2022-03-08$2.61/sh+100,000$261,000→ 347,200 total
Exercise: $2.61Exp: 2032-03-08→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]Options issued under the NRX Pharmaceuticals, Inc. 2021 Omnibus Incentive Plan. The options vest on March 8, 2023, generally subject to the Reporting Person's continued service for NRX Pharmaceuticals, Inc.

Documents

1 file

4
es220233694_4-besthof.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

NRX Pharmaceuticals, Inc.

CIK 0001719406

Entity typeother

Related Parties

1

filerCIK 0001864650

Filing Metadata

Form type: 4
Filed: Mar 9, 7:00 PM ET
Accepted: Mar 10, 4:04 PM ET
Size: 5.5 KB

View on SEC.gov